Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Judy Nee, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Judy Nee and Sarah Ballou.
Judy Nee
Connection Strength
6.444
Sarah Ballou
  1. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021 Jun 07.
    View in: PubMed
    Score: 0.941
  2. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol. 2019 12; 17(13):2696-2703.
    View in: PubMed
    Score: 0.809
  3. Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
    View in: PubMed
    Score: 0.248
  4. Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20.
    View in: PubMed
    Score: 0.246
  5. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol. 2021 11 01; 116(11):2279-2285.
    View in: PubMed
    Score: 0.242
  6. Clinical and Psychological Factors Predict Outcome in Patients With Functional Dyspepsia: A Prospective Study. Clin Gastroenterol Hepatol. 2021 Jul 31.
    View in: PubMed
    Score: 0.238
  7. Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation. J Clin Gastroenterol. 2020 04; 54(4):365-369.
    View in: PubMed
    Score: 0.217
  8. Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci. 2020 11; 65(11):3260-3270.
    View in: PubMed
    Score: 0.216
  9. Placebo Response in Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 12; 114(12):1838-1846.
    View in: PubMed
    Score: 0.212
  10. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2019 12; 10(12):e00110.
    View in: PubMed
    Score: 0.212
  11. Prevalence of Functional GI Diseases and Pelvic Floor Symptoms in Marfan Syndrome and Ehlers-Danlos Syndrome: A National Cohort Study. J Clin Gastroenterol. 2019 10; 53(9):653-659.
    View in: PubMed
    Score: 0.209
  12. Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2019 11; 50(9):1019-1024.
    View in: PubMed
    Score: 0.209
  13. Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey. Clin Gastroenterol Hepatol. 2019 11; 17(12):2471-2478.e3.
    View in: PubMed
    Score: 0.207
  14. Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia. J Neurogastroenterol Motil. 2019 Jan 31; 25(1):129-136.
    View in: PubMed
    Score: 0.200
  15. Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States. Am J Gastroenterol. 2019 01; 114(1):135-142.
    View in: PubMed
    Score: 0.199
  16. Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic. Dig Dis Sci. 2018 11; 63(11):2983-2991.
    View in: PubMed
    Score: 0.193
  17. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation. Clin Gastroenterol Hepatol. 2018 11; 16(11):1738-1744.e1.
    View in: PubMed
    Score: 0.189
  18. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Aliment Pharmacol Ther. 2018 Apr; 47(7):913-921.
    View in: PubMed
    Score: 0.187
  19. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 10; 16(10):1569-1584.e2.
    View in: PubMed
    Score: 0.186
  20. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.178
  21. Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice. J Clin Invest. 2022 01 18; 132(2).
    View in: PubMed
    Score: 0.061
  22. Belching: Pathogenesis, Clinical Characteristics, and Treatment Strategies. J Clin Gastroenterol. 2022 01 01; 56(1):36-40.
    View in: PubMed
    Score: 0.061
  23. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders. Neurogastroenterol Motil. 2022 Apr; 34(4):e14253.
    View in: PubMed
    Score: 0.060
  24. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
    View in: PubMed
    Score: 0.060
  25. Symptom severity and clinical characteristics of patients with bloating. Neurogastroenterol Motil. 2022 Mar; 34(3):e14229.
    View in: PubMed
    Score: 0.060
  26. Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders. Am J Gastroenterol. 2021 08 01; 116(8):1720-1726.
    View in: PubMed
    Score: 0.059
  27. Fecal Urgency: Clinical and Manometric Characteristics in Patients With and Without Diarrhea. Dig Dis Sci. 2020 12; 65(12):3679-3687.
    View in: PubMed
    Score: 0.055
  28. Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2020 12; 18(13):2945-2951.e1.
    View in: PubMed
    Score: 0.054
  29. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2020 02; 18(2):399-405.e1.
    View in: PubMed
    Score: 0.052
  30. Fecal urgency is common in constipated patients and is associated with anxiety. Neurogastroenterol Motil. 2019 04; 31(4):e13545.
    View in: PubMed
    Score: 0.050
  31. Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013. J Clin Gastroenterol. 2019 02; 53(2):109-113.
    View in: PubMed
    Score: 0.050
  32. Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department. Dig Dis Sci. 2019 05; 64(5):1320-1327.
    View in: PubMed
    Score: 0.049
  33. Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013. J Clin Gastroenterol. 2018 10; 52(9):778-783.
    View in: PubMed
    Score: 0.049
  34. Clinical and manometric characteristics of women with paradoxical puborectalis syndrome. United European Gastroenterol J. 2018 Dec; 6(10):1578-1585.
    View in: PubMed
    Score: 0.049
  35. Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. Am J Gastroenterol. 2018 04; 113(4):593-600.
    View in: PubMed
    Score: 0.047
  36. Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2018 09; 16(9):1450-1458.e2.
    View in: PubMed
    Score: 0.047
  37. Characterizing Normal Bowel Frequency and Consistency in a Representative Sample of Adults in the United States (NHANES). Am J Gastroenterol. 2018 01; 113(1):115-123.
    View in: PubMed
    Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.